Ygot, Estrella L.
HRN: 24-50-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
CO-AMOXICLAV 625MG (TAB)
12/30/2025
01/06/2026
PO
500
Q12
Cellulitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes